Biofrontera Historical Balance Sheet

BFRIW Stock

USD 0.10 0.02 16.67%

Trend analysis of Biofrontera Warrants balance sheet accounts such as Short Long Term Debt Total of 4.6 M, Other Current Liabilities of 6.4 M or Total Current Liabilities of 15.2 M provides information on Biofrontera Warrants' total assets, liabilities, and equity, which is the actual value of Biofrontera Warrants to its prevalent stockholders. By breaking down trends over time using Biofrontera Warrants balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Biofrontera Warrants latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biofrontera Warrants is a good buy for the upcoming year.

Biofrontera Warrants Inventory

8.82 Million

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Biofrontera Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biofrontera Warrants at a specified time, usually calculated after every quarter, six months, or one year. Biofrontera Warrants Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biofrontera Warrants and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biofrontera currently owns. An asset can also be divided into two categories, current and non-current.

Biofrontera Warrants Balance Sheet Chart

At this time, Biofrontera Warrants' Property Plant And Equipment Gross is fairly stable compared to the past year. Total Current Assets is likely to climb to about 34.2 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 15.2 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Total Assets

Total assets refers to the total amount of Biofrontera Warrants assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biofrontera Warrants books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biofrontera Warrants balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biofrontera Warrants are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Biofrontera Warrants' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biofrontera Warrants current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2023	2024	2025 (projected)
Short and Long Term Debt Total	5.4M	4.9M	4.6M
Total Assets	27.9M	32.1M	40.7M

Short Long Term Debt Total Total Assets

Biofrontera Warrants balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Non Current Liabilities Other	Net Working Capital
Total Assets		-0.58	0.13	0.54	0.67	0.3	-0.73	-0.59	0.1	0.7	0.95	0.93	-0.24	0.78	0.39	0.28	-0.44	-0.71	0.63	0.6	-0.34	0.8	0.28	1.0	-0.57	0.66
Short Long Term Debt Total	-0.58		0.71	-0.44	-0.98	-0.63	0.95	0.88	-0.59	-0.19	-0.47	-0.51	0.43	-0.3	-0.2	-0.68	0.95	0.56	-0.69	-0.89	0.95	-0.51	-0.67	-0.59	0.63	-0.22
Other Current Liab	0.13	0.71		-0.09	-0.59	-0.54	0.51	0.6	-0.73	0.42	0.24	0.22	0.46	0.4	0.15	-0.63	0.76	0.02	-0.4	-0.58	0.84	0.15	-0.64	0.12	0.31	0.35
Total Current Liabilities	0.54	-0.44	-0.09		0.53	0.79	-0.38	-0.74	0.58	-0.02	0.61	0.44	-0.35	0.18	0.84	0.82	-0.57	0.12	0.39	0.79	-0.42	0.69	0.73	0.53	-0.93	-0.09
Total Stockholder Equity	0.67	-0.98	-0.59	0.53		0.63	-0.96	-0.87	0.52	0.29	0.59	0.63	-0.36	0.43	0.33	0.67	-0.93	-0.58	0.65	0.9	-0.92	0.65	0.64	0.67	-0.67	0.3
Property Plant And Equipment Net	0.3	-0.63	-0.54	0.79	0.63		-0.42	-0.84	0.9	-0.42	0.37	0.09	-0.73	-0.2	0.68	0.86	-0.83	0.16	0.31	0.8	-0.72	0.51	0.98	0.29	-0.91	-0.46
Net Debt	-0.73	0.95	0.51	-0.38	-0.96	-0.42		0.78	-0.35	-0.48	-0.59	-0.72	0.25	-0.55	-0.13	-0.52	0.82	0.75	-0.73	-0.81	0.83	-0.57	-0.46	-0.74	0.51	-0.5
Retained Earnings	-0.59	0.88	0.6	-0.74	-0.87	-0.84	0.78		-0.81	0.01	-0.51	-0.43	0.57	-0.11	-0.42	-0.87	0.91	0.27	-0.73	-0.96	0.84	-0.53	-0.88	-0.59	0.9	0.02
Accounts Payable	0.1	-0.59	-0.73	0.58	0.52	0.9	-0.35	-0.81		-0.57	0.08	-0.16	-0.8	-0.47	0.33	0.84	-0.77	0.23	0.44	0.72	-0.7	0.14	0.96	0.1	-0.77	-0.58
Cash	0.7	-0.19	0.42	-0.02	0.29	-0.42	-0.48	0.01	-0.57		0.6	0.86	0.43	0.94	-0.09	-0.27	0.09	-0.81	0.38	0.08	0.08	0.43	-0.44	0.71	0.11	0.99
Non Current Assets Total	0.95	-0.47	0.24	0.61	0.59	0.37	-0.59	-0.51	0.08	0.6		0.87	-0.28	0.75	0.6	0.25	-0.4	-0.57	0.4	0.54	-0.28	0.92	0.31	0.94	-0.6	0.54
Non Currrent Assets Other	0.93	-0.51	0.22	0.44	0.63	0.09	-0.72	-0.43	-0.16	0.86	0.87		0.11	0.94	0.33	0.18	-0.33	-0.76	0.53	0.51	-0.27	0.78	0.05	0.93	-0.39	0.83
Long Term Debt	-0.24	0.43	0.46	-0.35	-0.36	-0.73	0.25	0.57	-0.8	0.43	-0.28	0.11		0.36	-0.27	-0.46	0.55	-0.06	-0.31	-0.46	0.47	-0.2	-0.78	-0.24	0.58	0.44
Cash And Short Term Investments	0.78	-0.3	0.4	0.18	0.43	-0.2	-0.55	-0.11	-0.47	0.94	0.75	0.94	0.36		0.21	-0.13	-0.08	-0.77	0.27	0.22	-0.06	0.68	-0.27	0.78	-0.08	0.92
Net Receivables	0.39	-0.2	0.15	0.84	0.33	0.68	-0.13	-0.42	0.33	-0.09	0.6	0.33	-0.27	0.21		0.51	-0.39	0.22	-0.12	0.49	-0.24	0.8	0.54	0.36	-0.73	-0.17
Common Stock Shares Outstanding	0.28	-0.68	-0.63	0.82	0.67	0.86	-0.52	-0.87	0.84	-0.27	0.25	0.18	-0.46	-0.13	0.51		-0.8	0.15	0.56	0.91	-0.74	0.35	0.88	0.28	-0.86	-0.28
Non Current Liabilities Total	-0.44	0.95	0.76	-0.57	-0.93	-0.83	0.82	0.91	-0.77	0.09	-0.4	-0.33	0.55	-0.08	-0.39	-0.8		0.29	-0.53	-0.91	0.98	-0.52	-0.85	-0.44	0.75	0.08
Inventory	-0.71	0.56	0.02	0.12	-0.58	0.16	0.75	0.27	0.23	-0.81	-0.57	-0.76	-0.06	-0.77	0.22	0.15	0.29		-0.51	-0.26	0.32	-0.42	0.14	-0.73	0.0	-0.84
Other Current Assets	0.63	-0.69	-0.4	0.39	0.65	0.31	-0.73	-0.73	0.44	0.38	0.4	0.53	-0.31	0.27	-0.12	0.56	-0.53	-0.51		0.71	-0.51	0.18	0.42	0.65	-0.51	0.39
Other Stockholder Equity	0.6	-0.89	-0.58	0.79	0.9	0.8	-0.81	-0.96	0.72	0.08	0.54	0.51	-0.46	0.22	0.49	0.91	-0.91	-0.26	0.71		-0.85	0.59	0.82	0.61	-0.87	0.07
Total Liab	-0.34	0.95	0.84	-0.42	-0.92	-0.72	0.83	0.84	-0.7	0.08	-0.28	-0.27	0.47	-0.06	-0.24	-0.74	0.98	0.32	-0.51	-0.85		-0.4	-0.75	-0.34	0.61	0.05
Net Invested Capital	0.8	-0.51	0.15	0.69	0.65	0.51	-0.57	-0.53	0.14	0.43	0.92	0.78	-0.2	0.68	0.8	0.35	-0.52	-0.42	0.18	0.59	-0.4		0.4	0.78	-0.66	0.36
Property Plant And Equipment Gross	0.28	-0.67	-0.64	0.73	0.64	0.98	-0.46	-0.88	0.96	-0.44	0.31	0.05	-0.78	-0.27	0.54	0.88	-0.85	0.14	0.42	0.82	-0.75	0.4		0.28	-0.89	-0.46
Total Current Assets	1.0	-0.59	0.12	0.53	0.67	0.29	-0.74	-0.59	0.1	0.71	0.94	0.93	-0.24	0.78	0.36	0.28	-0.44	-0.73	0.65	0.61	-0.34	0.78	0.28		-0.56	0.67
Non Current Liabilities Other	-0.57	0.63	0.31	-0.93	-0.67	-0.91	0.51	0.9	-0.77	0.11	-0.6	-0.39	0.58	-0.08	-0.73	-0.86	0.75	0.0	-0.51	-0.87	0.61	-0.66	-0.89	-0.56		0.17
Net Working Capital	0.66	-0.22	0.35	-0.09	0.3	-0.46	-0.5	0.02	-0.58	0.99	0.54	0.83	0.44	0.92	-0.17	-0.28	0.08	-0.84	0.39	0.07	0.05	0.36	-0.46	0.67	0.17

Click cells to compare fundamentals

Biofrontera Warrants Account Relationship Matchups

Biofrontera Warrants balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Other Current Liab	2.9M	9.9M	11.7M	4.6M	4.1M	6.4M
Total Current Liabilities	4.4M	13.8M	20.9M	18.1M	20.8M	15.2M
Total Stockholder Equity	5.8M	11.3M	23.9M	4.8M	5.5M	3.4M
Property Plant And Equipment Net	370K	267K	1.6M	1.7M	2.0M	2.1M
Net Debt	(8.1M)	(24.5M)	(15.9M)	4.1M	3.7M	3.8M
Retained Earnings	(41.2M)	(78.9M)	(79.5M)	(99.7M)	(89.7M)	(94.2M)
Accounts Payable	1.5M	658K	1.3M	8.9M	10.2M	10.8M
Cash	8.1M	24.5M	17.2M	1.3M	1.2M	1.1M
Non Current Assets Total	4.6M	6.8M	7.7M	4.9M	5.6M	6.4M
Non Currrent Assets Other	323K	3.1M	3.1M	482K	554.3K	526.6K
Cash And Short Term Investments	8.1M	24.5M	27.8M	1.4M	1.6M	1.6M
Net Receivables	3.3M	3.8M	7.4M	5.2M	5.9M	5.4M
Common Stock Shares Outstanding	580K	855.2K	1.1M	1.5M	1.8M	1.0M
Liabilities And Stockholders Equity	24.1M	53.2M	50.9M	27.9M	32.1M	40.7M
Non Current Liabilities Total	13.9M	28.0M	6.1M	5.1M	4.5M	4.3M
Inventory	7.1M	4.5M	7.2M	10.9M	12.5M	8.8M
Other Current Assets	1.1M	13.6M	810K	5.6M	6.4M	4.7M
Other Stockholder Equity	47.0M	90.2M	103.4M	104.4M	120.1M	82.5M
Total Liab	18.3M	41.9M	27.0M	23.1M	20.8M	27.1M
Net Invested Capital	5.8M	11.3M	23.9M	8.7M	10.0M	12.7M
Property Plant And Equipment Gross	661K	673K	1.6M	2.3M	2.6M	2.8M
Total Current Assets	19.6M	46.4M	43.1M	23.1M	26.5M	34.2M
Capital Stock	8K	17K	27K	2K	2.3K	2.2K
Non Current Liabilities Other	13.9M	5.6M	21K	37K	33.3K	31.6K
Net Working Capital	15.2M	32.6M	22.2M	5.0M	4.5M	4.3M
Intangible Assets	3.9M	3.5M	3.0M	2.6M	2.4M	2.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biofrontera Historical Balance Sheet

Biofrontera Warrants Inventory

8.82 Million

About Biofrontera Balance Sheet Analysis

Biofrontera Warrants Balance Sheet Chart

Total Assets

Total Current Liabilities

Biofrontera Warrants balance sheet Correlations

Biofrontera Warrants Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biofrontera Warrants balance sheet Accounts

Also Currently Popular

Additional Tools for Biofrontera Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 0.99	Cash
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Total Liab	+ 0.98	Non Current Liabilities Total
Property Plant And Equipment Gross	+ 0.96	Accounts Payable
Non Current Assets Total	+ 0.95	Total Assets

Total Stockholder Equity	- 0.98	Short Long Term Debt Total
Other Stockholder Equity	- 0.96	Retained Earnings
Net Debt	- 0.96	Total Stockholder Equity
Non Current Liabilities Total	- 0.93	Total Stockholder Equity
Non Current Liabilities Other	- 0.93	Total Current Liabilities
Total Liab	- 0.92	Total Stockholder Equity